Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN
· Real-Time Price · USD
4.13
0.02 (0.49%)
At close: May 14, 2025, 3:59 PM
4.05
-1.94%
After-hours: May 14, 2025, 07:15 PM EDT
0.49% (1D)
| Bid | 4.05 |
| Market Cap | 44.54M |
| Revenue (ttm) | 100.65K |
| Net Income (ttm) | -20.78M |
| EPS (ttm) | -1.93 |
| PE Ratio (ttm) | -2.14 |
| Forward PE | -3.68 |
| Analyst | Buy |
| Ask | 4.74 |
| Volume | 31,114 |
| Avg. Volume (20D) | 40,045 |
| Open | 4.36 |
| Previous Close | 4.11 |
| Day's Range | 4.06 - 4.46 |
| 52-Week Range | 2.55 - 6.80 |
| Beta | 1.62 |
About LTRN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LTRN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LTRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+4.27%
Lantern Pharma shares are trading higher after the...
Unlock content with
Pro Subscription
5 months ago
+0.95%
Lantern Pharma shares are trading higher after the company announced LP-184 received its second fast-track designation status from the FDA for the treatment of triple-negative breast cancer.
